Libsyn Directory

Episode 528 - Lana Melendres-Groves, MD

I'm Aware That I'm Rare: the phaware® podcast

Release Date: 07/08/2025

I'm Aware That I'm Rare: the phaware® podcast

Dr. Robert Frantz breaks down the key metrics behind risk stratification—functional class, six-minute walk distance, and brain natriuretic peptide levels—and explains how they shape treatment plans. He also explores the role of echocardiography, right heart catheterization, and cutting-edge therapies in improving patient outcomes. Read the proceedings of the from the Seventh World Symposium on Pulmonary Hypertension. This Special Edition Episode Sponsored by: Learn more about pulmonary hypertension trials at . Follow us on social @phaware Engage for a cure: #phaware Share...

Jean M Elwing, MD - phaware® interview 532

I'm Aware That I'm Rare: the phaware® podcast

ICU & You: What Happens When Pulmonary Hypertension Turns Critical? Pulmonary hypertension is already a complex condition, but what happens when it becomes life-threatening? Dr. Jean Elwing breaks down what patients and families can expect when someone with PH ends up in the ICU. My name is Dr. Jean Elwing, and I'm a professor of medicine, and I'm the director of the Pulmonary Hypertension Program at the University of Cincinnati, and I've been there about two decades now, really focused the entire time on the care of patients with pulmonary hypertension and related illnesses. Over that...

Episode 532 - Jean M Elwing, MD

I'm Aware That I'm Rare: the phaware® podcast

ICU & You: What Happens When Pulmonary Hypertension Turns Critical? Pulmonary hypertension is already a complex condition, but what happens when it becomes life-threatening? Dr. Jean Elwing breaks down what patients and families can expect when someone with PH ends up in the ICU. Learn more about pulmonary hypertension trials at . Engage for a cure: #phaware Share your story: Like, Subscribe and Follow us: . #phawareMD

John Granton, MD - phaware® interview 531

I'm Aware That I'm Rare: the phaware® podcast

Dr. John Granton, a critical care and transplant physician at Toronto General Hospital, shares his journey in pulmonary hypertension and lung transplantation, detailing the groundbreaking advancements in transplant technology. He discusses the evolution of lung preservation methods, the challenges of chronic rejection, and the hope for longer-lasting transplants. With a passion for improving patient outcomes, Dr. Granton envisions a future where transplant becomes obsolete—replaced by treatments that cure underlying diseases. My name is John Granton. I'm in Toronto. That's where I was...

Episode 531 - John Granton, MD

I'm Aware That I'm Rare: the phaware® podcast

Dr. John Granton, a critical care and transplant physician at Toronto General Hospital, shares his journey in pulmonary hypertension and lung transplantation, detailing the groundbreaking advancements in transplant technology. He discusses the evolution of lung preservation methods, the challenges of chronic rejection, and the hope for longer-lasting transplants. With a passion for improving patient outcomes, Dr. Granton envisions a future where transplant becomes obsolete—replaced by treatments that cure underlying diseases. Learn more about pulmonary hypertension trials at . Engage...

First 5 Minutes® - phaware® interview 530

I'm Aware That I'm Rare: the phaware® podcast

In this episode, Drs. Victor Test, Deborah Levine and Rodolfo Estrada discuss CHEST’s program, which helps medical professionals build the skills that lead to a positive relationship with patients from the get-go. The goal is to improve patient care, shorten time to diagnosis for complex or rare diseases like pulmonary hypertension, and increase patient compliance and buy-in to their treatment plan. Victor Test, MD, FCCP: I'm Dr. Victor Test, Chief of Pulmonary Medicine and Critical Care at Texas Tech University in Lubbock, Texas and Director of the Pulmonary Vascular program. Deborah...

Episode 530 - First 5 Minutes®

I'm Aware That I'm Rare: the phaware® podcast

In this episode, Drs. Victor Test, Deborah Levine and Rodolfo Estrada discuss CHEST’s program, which helps medical professionals build the skills that lead to a positive relationship with patients from the get-go. The goal is to improve patient care, shorten time to diagnosis for complex or rare diseases like pulmonary hypertension, and increase patient compliance and buy-in to their treatment plan. Learn more about pulmonary hypertension trials at . Engage for a cure: #phaware Share your story: Like, Subscribe and Follow us: . #phawareMD ...

Lia Barros, DNP and Tijana Milinic, MD - phaware® interview 529

I'm Aware That I'm Rare: the phaware® podcast

Dr. Tijana Milinic and Lia Barros, DNP, from the University of Washington take a deep dive into the world of pulmonary arterial hypertension (PAH) clinical trials and discuss why diversity and inclusion matter. They explore the hidden biases in medical research and the real-world consequences of exclusion. Lia Barros, DNP: My name is Lia Barros and I'm a pulmonary vascular disease nurse practitioner specialist. I work at the University of Washington, where I've been practicing as a pulmonary vascular disease specialist for about the last four years. I was born and raised in this area. I'm...

Episode 529 - Lia Barros, DNP and Tijana Milinic, MD

I'm Aware That I'm Rare: the phaware® podcast

Dr. Tijana Milinic and Lia Barros, DNP, from the University of Washington take a deep dive into the world of pulmonary arterial hypertension (PAH) clinical trials and discuss why diversity and inclusion matter. They explore the hidden biases in medical research and the real-world consequences of exclusion. Learn more about pulmonary hypertension trials at . Engage for a cure: #phaware Share your story: Like, Subscribe and Follow us: . #phawareMD

Lana Melendres-Groves, MD - phaware® interview 528

I'm Aware That I'm Rare: the phaware® podcast

Dr. Lana Melendres-Groves dives into her research on racial and ethnic disparities in PAH treatment. From differences in medication access to the role of social determinants of health, she explores how systemic barriers impact care and what steps can be taken to ensure equity and inclusivity in PAH management. Hi, I am Lana Melendres-Groves. I'm at the University of New Mexico. I’m the Pulmonary Hypertension Medical Director of our Comprehensive Care Center. Today, I hope to dive into a little bit of the information that we have regarding how we care for different subgroups of our patients...

More Episodes

Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Engage for a cure: www.phaware.global/donate #phaware Share your story: [email protected] Like, Subscribe and Follow us: www.phawarepodcast.com. @UNMHSC #phawareMD

TOPICS